Skip to main content
OpenTrials

Clinical trial condition

Hypereosinophilic Syndrome

Explore clinical trials studying Hypereosinophilic Syndrome. Study availability and eligibility vary by location and protocol.

20 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Hypereosinophilic Syndrome trial results

Recruiting

Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial

NCT05334368

Conditions
Eosinophilia, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations
  • GSK Investigational Site San Diego, California, United States
  • GSK Investigational Site Atlanta, Georgia, United States
  • GSK Investigational Site Boston, Massachusetts, United States
  • GSK Investigational Site Southfield, Michigan, United States
View all 93 locations
View Trial Details
Active, not recruiting

Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders

NCT03801434

Conditions
BCR-JAK2 Fusion Protein Expression, Blasts 20 Percent or Less of Peripheral Blood White Cells, Blasts More Than 5 Percent of Bone Marrow Nucleated Cells, +17 more
Locations
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • OHSU Knight Cancer Institute Portland, Oregon, United States
  • University of Utah Salt Lake City, Utah, United States
  • Fred Hutchinson cancer research center Seattle, Washington, United States
View Trial Details
Active, not recruiting

A Phase III Study to Evaluate the Efficacy and Safety of Benralizumab in Patients With Hypereosinophilic Syndrome (HES)

NCT04191304

Conditions
Eosinophilia, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Bethesda, Maryland, United States
  • Research Site Ann Arbor, Michigan, United States
View all 52 locations
View Trial Details
Completed

Study in Pediatrics With HypEREosinophilic Syndrome (SPHERE)

NCT04965636

Conditions
Eosinophilia, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations
  • GSK Investigational Site Rochester, Minnesota, United States
  • GSK Investigational Site Cincinnati, Ohio, United States
  • GSK Investigational Site Cleveland, Ohio, United States
  • GSK Investigational Site Charleston, South Carolina, United States
View all 14 locations
View Trial Details

Related conditions